SELVAS Healthcare, Inc. (KOSDAQ:208370)
2,280.00
-10.00 (-0.44%)
At close: Oct 23, 2026
SELVAS Healthcare Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 31,691 | 30,825 | 31,702 | 29,813 | 27,686 | 29,089 |
Revenue Growth | 0.04% | -2.77% | 6.34% | 7.68% | -4.83% | 37.52% |
Gross Profit Gross Profit Growth | 15,552 | 14,998 | 16,561 | 15,650 | 13,985 | 13,853 |
Operating Income Operating Income Growth | 1,560 | -161.56 | 3,275 | 3,349 | 2,486 | 3,416 |
Net Income Net Income Growth | 8,698 | 3,889 | 3,152 | 5,170 | 2,813 | 2,472 |
Earnings Per Share EPS Growth | 340.04 | 151.00 | 122.00 | 214.00 | 94.38 | 114.00 |
EPS Growth | 337.34% | 23.77% | -42.99% | 126.75% | -17.21% | 225.71% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Medical Diagnosis Division Medical Diagnosis Division Growth | 17,933 | 17,598 | 19,423 | 15,752 | 13,851 | 16,852 |
Assistive Technology Division Assistive Technology Division Growth | 15,660 | 15,455 | 14,953 | 16,819 | 13,835 | 12,238 |
Consolidation Adjustment Consolidation Adjustment Growth | -1,902 | -2,229 | -2,673 | -2,758 | - | - |
Total Total Growth | 31,691 | 30,825 | 31,702 | 29,813 | 27,686 | 29,089 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 27,574 | 26,376 | 26,089 | 24,280 | 7,061 | 14,872 |
Total Debt Total Debt Growth | 2,590 | 1,725 | 2,996 | 3,239 | 7,833 | 16,753 |
Net Cash (Debt) Net Cash Growth | 24,983 | 24,652 | 23,092 | 21,041 | -771.46 | -1,881 |
Net Cash Growth | 27.40% | 6.75% | 9.75% | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | 976.46 | 955.37 | 894.97 | 870.30 | -32.65 | -86.85 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 2,964 | 304.75 | 4,500 | 3,472 | 50.81 | 2,928 |
Capital Expenditures CapEx Growth | -1,663 | -856.8 | -716.31 | -359.64 | -352.31 | -371.2 |
Free Cash Flow Free Cash Flow Growth | 1,302 | -552.04 | 3,783 | 3,112 | -301.51 | 2,557 |
Free Cash Flow Growth | -29.99% | - | 21.57% | - | - | -37.46% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 49.07% | 48.66% | 52.24% | 52.50% | 50.51% | 47.62% |
Operating Margin | 4.92% | -0.52% | 10.33% | 11.23% | 8.98% | 11.74% |
Pretax Margin | 30.49% | 15.74% | 10.41% | 12.94% | 10.30% | 8.72% |
Profit Margin | 27.45% | 12.62% | 9.94% | 17.34% | 10.16% | 8.50% |
FCF Margin | 4.11% | -1.79% | 11.93% | 10.44% | -1.09% | 8.79% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 6.71 | 38.42 | 33.09 | 33.90 | 16.09 | 26.29 |
Forward PE | - | 20.30 | 20.30 | 20.30 | 20.30 | 20.30 |
P/FCF Ratio | 45.05 | - | 27.56 | 56.31 | - | 25.41 |
PS Ratio | 1.85 | 4.85 | 3.29 | 5.88 | 1.64 | 2.23 |